New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - acitretin 25mg;   - capsule - 25 mg - active: acitretin 25mg   excipient: gelatin   glucose liquid iron oxide black iron oxide red iron oxide yellow   microcrystalline cellulose sodium ascorbate titanium dioxide   - neotigason is indicated for the following indications: · severe psoriasis · disorders of keratinization, such as ichthyotic disorders, palmoplantar keratoderma, darier's disease and lichen planus. · other dermatoses responsive to etretinate.

New Zealand - English - Medsafe (Medicines Safety Authority)

emcure nz limited - sumatriptan succinate 16.8 mg/ml equivalent to sumatriptan 12 mg - solution for injection - 6 mg/0.5ml - active: sumatriptan succinate 16.8 mg/ml equivalent to sumatriptan 12 mg excipient: nitrogen sodium chloride water for injection - indicated for the acute relief of migraine attacks with or without aura

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - tramadol hydrochloride 100mg - modified release tablet - 100 mg - active: tramadol hydrochloride 100mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide hyprolose magnesium stearate - relief of moderate to severe pain

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - tramadol hydrochloride 150mg - modified release tablet - 150 mg - active: tramadol hydrochloride 150mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide hyprolose magnesium stearate - relief of moderate to severe pain

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - tramadol hydrochloride 200mg - modified release tablet - 200 mg - active: tramadol hydrochloride 200mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide hyprolose magnesium stearate - relief of moderate to severe pain

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - levonorgestrel 0.75mg - tablet - 0.75 mg - active: levonorgestrel 0.75mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone sunset yellow fcf - next choice is an oral emergency contraceptive indicated for use within 72 hours of unprotected intercourse. it should be used only as an emergency measure. women who present for repeated courses of emergency contraception should be advised to consider long-term methods of contraception.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - levonorgestrel 0.75mg - tablet - 750 mcg - active: levonorgestrel 0.75mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone sunset yellow fcf - next choice is an oral emergency contraceptive indicated for use within 72 hours of unprotected intercourse. it should be used only as an emergency measure. women who present for repeated courses of emergency contraception should be advised to consider long-term methods of contraception.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - latanoprost 0.05 mg/ml;  ;   - eye drops, solution - 50 mcg/ml - active: latanoprost 0.05 mg/ml     excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate monobasic sodium phosphate dihydrate purified water sodium chloride - reduction of elevated intraocular pressure in patients with ocular hypertension

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - ranitidine hydrochloride 16.75 mg/ml - syrup - 150 mg/10ml - active: ranitidine hydrochloride 16.75 mg/ml excipient: dibasic sodium phosphate ethanol mint flavour phl-069966 monobasic sodium phosphate dihydrate purified water saccharin sodium sorbitol - arrow-ranitidine syrup is indicated for the treatment of duodenal ulcer, and benign gastric ulcer, including that associated with non-steroidal anti- inflammatory agents.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - stavudine 40mg - capsule - 40 mg - active: stavudine 40mg excipient: gelatin lactose liquid paraffin magnesium stearate purified water sodium laurilsulfate   sodium starch glycolate tekprint black sw-9008 titanium dioxide - arrow - stavudine is indicated for the treatment of hiv-infected patients (over the age of 5 months) for whom zidovudine therapy is not, or is no longer, appropriate.